2012
Age at onset of epilepsy, pharmacoresistance, and cognitive outcomes
Berg AT, Zelko FA, Levy SR, Testa FM. Age at onset of epilepsy, pharmacoresistance, and cognitive outcomes. Neurology 2012, 79: 1384-1391. PMID: 22972641, PMCID: PMC3448745, DOI: 10.1212/wnl.0b013e31826c1b55.Peer-Reviewed Original Research
2008
Residual cognitive effects of uncomplicated idiopathic and cryptogenic epilepsy
Berg AT, Langfitt JT, Testa FM, Levy SR, DiMario F, Westerveld M, Kulas J. Residual cognitive effects of uncomplicated idiopathic and cryptogenic epilepsy. Epilepsy & Behavior 2008, 13: 614-619. PMID: 18675938, DOI: 10.1016/j.yebeh.2008.07.007.Peer-Reviewed Original ResearchConceptsCryptogenic epilepsyChildhood-onset epilepsyOngoing prospective studyNormal intelligenceStandardized neuropsychological assessmentResidual cognitive deficitsProspective studyRemission statusResidual cognitive effectsCohort 8Drug useEpilepsyCognitive deficitsSibling controlsSlower processing speedNeuropsychological assessmentCognitive effectsYoung peopleFull Scale IQCases